GDGuo-Chen Duan

Guo-Chen Duan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guo-Chen Duan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Hua Zhang

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang 050051, Hebei, PR China

    4 shared publications
  • Qingtao Zhao

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, People’s Republic of China

    4 shared publications
  • Xiao-Peng Zhang

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang 050051, Hebei, PR China

    3 shared publications
  • Zheng Yuan

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China

    3 shared publications
  • Hui-En Wang

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China

    2 shared publications
  • Zhi-Kang Wang

    Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis

    by Qing-Tao Zhao, Xiao-Peng Zhang, Hua Zhang, Guo-Chen Duan

    Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis


  • Prognostic role of platelet to lymphocyte ratio in non‐small cell lung cancers: A meta‐analysis including 3,720 patients

    by Qing‐Tao Zhao, Zheng Yuan, Hua Zhang, Xiao‐Peng Zhang, Hui‐En Wang, Zhi‐Kang Wang, Guo‐Chen Duan

    Platelet to lymphocyte ratio (PLR) was recently reported as a useful index in predicting the prognosis of lung cancer. However, the prognostic role of PLR in lung cancer remains controversial. The aim of this study was to evaluate the association between PLR and clinical outcome of lung cancer patients through a meta‐analysis. Relevant literatures were retrieved from PubMed, Ovid, the Cochrane Library and Web of Science databases. Meta‐analysis was performed using hazard ratio (HR) and 95% confidence intervals (CIs) as effect measures. A total of 5,314 patients from 13 studies were finally enrolled in the meta‐analysis. The summary results showed that elevated PLR predicted poorer overall survival (OS) (HR: 1.526, 95%CI: 1.268–1.836, p < 0.001) in patients with lung cancer and OS (HR: 1.631, 95%CI: 1.447–1.837, p < 0.001) in patients with nonsmall cell lung cancer (NSCLC). Subgroup analysis revealed that increased PLR was also associated with poor OS in NSCLC treated by surgical resection (HR: 1.884, 95%CI: 1.308‐2.714, P < 0.001) and non‐surgery (HR: 1.570, 95%CI: 1.323‐1.863, P < 0.001). In addition, PLR Cut‐off value ≤ 160 (HR: 1.506, 95%CI: 1.292‐1.756, P < 0.001) and PLR Cut‐off value>160 (HR: 1.842, 95%CI: 1.523‐2.228, P < 0.001). In contrast, elevated PLR was not associated with OS (HR: 1.117, 95%CI: 0.796‐1.569, P > 0.05) in patients with small cell lung cancer (SCLC).This meta‐analysis result suggested that elevated PLR might be a predicative factor of poor prognosis for NSCLC patients.


  • Open Access

    Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis

    by Guo-Chen Duan, Qing-Tao Zhao, Tao Guo, Hui-En Wang, Xiao-Peng Zhang, Hua Zhang, Zhi-Kang Wang, Zheng Yuan

    The diagnostic value of SHOX2 DNA methylation in patients with lung cancer remains controversial. Thus, we performed a systematic review and meta-analysis to assess diagnostic accuracy of SHOX2 DNA methylation in the lymph node, bronchial aspirates, pleural effusion, plasma, and tumor tissue for lung cancer. We conducted a comprehensive literature search in PubMed, Ovid, the Cochrane library, and Web of Science databases in May 2015. The diagnostic sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curve were pooled using STATA 12.0 software. A total of 2,296 subjects included 1,129 lung cancer patients in eight studies were recruited in this meta-analysis. The summary estimates for SHOX2 DNA methylation in the diagnosis of lung cancer in these studies were pooled SEN =0.70 (95% confidence interval [CI]: 0.46–0.87), SPE =0.96 (95% CI: 0.91–0.99), PLR 20.01 (95% CI: 6.96–57.52), NLR 0.31 (95% CI: 0.15–0.64), and DOR 65.11 (95% CI: 13.10–323.61), and the area under the curve (AUC) was 0.96 (95% CI: 0.94–0.97). SHOX2 DNA methylation has greater diagnostic value in detecting lung cancer. In addition, considering the potential publication bias and high heterogeneity, further research studies with more well-designed and large sample sizes are needed in the future.


  • Open Access

    Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients

    by Guo-Chen Duan, Qing-Tao Zhao, Yong Yang, Shun Xu, Xiao-Peng Zhang, Hui-En Wang, Hua Zhang, Zhi-Kang Wang, Zheng Yuan

    Background: Neutrophil to lymphocyte ratio (NLR) has recently been reported to be a poor prognostic indicator in lung cancer. However, the prognostic value of the NLR in patients with lung cancer still remains controversial. We performed a meta-analysis to evaluate the prognostic value of NLR in patients with lung cancer. Methods: We performed a comprehensive literature search in PubMed, Ovid, the Cochrane Library, and Web of Science databases in May 2015. Studies were assessed for quality using the Newcastle–Ottawa Scale. Results: Twenty-two studies with a total of 7,054 patients were included in this meta-analysis. The meta-analysis was performed to generate combined hazard ratios (HRs) for overall survival (OS) and progression-free survival (PFS). Our analysis results indicated that high NLR predicted poorer OS (HR, 1.51; 95% confidence interval [CI], 1.33–1.71; PP=0.012) in patients with lung cancer. High NLR was also associated with poor OS in lung cancer treated by surgical resection (HR, 1.59; 95% CI, 1.26–1.99; PPP=0.003) and NLR cut-off value PConclusion: This meta-analysis result suggested that NLR should have significant predictive ability for estimating OS and PFS in patients with lung cancer and may be as a significant biomarker in the prognosis of lung cancer.